Frédéric Oudéa proposed as non-executive chairman of the board of directors of Sanofi
[ad_1]
Frédéric Oudéa, current CEO of Société Générale, will be proposed as the next non-executive chairman of the board of directors of Sanofi, the pharmaceutical group announced on Monday, September 5 in a press release.
Sanofi specifies that Mr. Oudéa was appointed censor on September 2 by the group’s board of directors, and that his appointment as director will be proposed at the next general meeting of shareholders.
Leaving Société Générale in 2023
Following this general meeting – the precise date of which has not yet been set, but which is usually held in the spring –, “It will be proposed to the Board of Directors of Sanofi the appointment of Frédéric Oudéa as non-executive chairman of this board, replacing Serge Weinberg whose term will have expired”. “Frédéric Oudéa has announced that he will step down as Chief Executive Officer and Director of Société Générale in May 2023”at the end of his current mandate, recalls Sanofi.
“Frédéric Oudéa and Paul Hudson, Chief Executive Officer of Sanofi, will form an excellent duo to position Sanofi as a modern healthcare company and strengthen its position as a French, European and global leader in the service of patients”commented Serge Weinberg, quoted in the press release.
“I am very happy to join Sanofi’s Board of Directors as a non-voting member, with, subject to the agreement of its shareholders, the prospect of taking over as Chairman. I am extremely motivated by the prospect of contributing in the coming years to the strategy and sustainable development of Sanofi, a leading company in a strategic health sector, with high impact and in full transformation, and to be the guarantor of quality group governance »said Mr. Oudéa.
[ad_2]
Source link
